Cartesian Therapeutics's market cap is currently $504.47M. The company's EPS TTM is $-52.639; its P/E ratio is ―; Cartesian Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 26.00M	$ 110.78M	$ 85.08M	$ 16.60M	$ 6.68M
Gross Profit	$ 24.45M	$ 108.74M	$ 85.08M	$ 16.60M	$ 6.68M
Operating Income	$ -86.42M	$ 14.54M	$ -4.60M	$ -56.82M	$ -52.45M
EBITDA	$ -235.06M	$ 39.84M	$ -5.16M	$ -65.59M	$ -51.80M
Net Income	$ -219.71M	$ 35.38M	$ -25.69M	$ -68.88M	$ -55.35M
Balance Sheet
Cash & Short-Term Investments	$ 76.91M	$ 134.60M	$ 128.06M	$ 138.69M	$ 90.17M
Total Assets	$ 305.05M	$ 165.89M	$ 159.88M	$ 165.44M	$ 99.57M
Total Debt	$ 10.96M	$ 37.92M	$ 35.28M	$ 35.35M	$ 19.28M
Net Debt	$ -65.96M	$ -68.51M	$ -78.78M	$ -103.34M	$ -70.89M
Total Liabilities	$ 745.23M	$ 72.06M	$ 137.36M	$ 183.44M	$ 91.17M
Stockholders' Equity	$ -440.18M	$ 93.83M	$ 22.52M	$ -18.01M	$ 8.40M
Cash Flow
Free Cash Flow	$ -51.37M	$ -32.83M	$ -61.47M	$ 34.07M	$ -51.48M
Operating Cash Flow	$ -51.16M	$ -31.63M	$ -60.38M	$ 34.88M	$ -51.44M
Investing Cash Flow	$ 34.61M	$ -15.00M	$ -17.14M	$ -741.00K	$ 229.00K
Financing Cash Flow	$ -13.14M	$ 39.22M	$ 52.90M	$ 14.43M	$ 105.04M

Currency in USD

Cartesian Therapeutics Earnings and Revenue History

Income Statement >

Cartesian Therapeutics Debt to Assets

Balance Sheet >

Cartesian Therapeutics Cash Flow

Cash Flow >

Cartesian Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing